Karyopharm Therapeutics, Inc. (KPTI)
9.06
+0.37
(+4.26%)
USD |
NASDAQ |
Jun 10, 16:00
8.93
-0.13
(-1.43%)
After-Hours: 20:00
Karyopharm Therapeutics Price : 9.06 for June 10, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 09, 2026 | 8.68 | 9.00 | 8.43 | 8.69 | 324139.0 |
| Jun 08, 2026 | 9.18 | 9.44 | 8.43 | 8.50 | 260161.0 |
| Jun 05, 2026 | 9.04 | 9.23 | 8.85 | 9.08 | 262518.0 |
| Jun 04, 2026 | 9.00 | 9.39 | 8.84 | 9.07 | 219177.0 |
| Jun 03, 2026 | 9.08 | 9.085 | 8.48 | 9.00 | 499732.0 |
| Jun 02, 2026 | 9.81 | 9.824 | 8.50 | 9.23 | 583777.0 |
| Jun 01, 2026 | 9.28 | 9.88 | 8.99 | 9.82 | 330039.0 |
| May 29, 2026 | 9.12 | 9.46 | 8.94 | 9.10 | 290712.0 |
| May 28, 2026 | 8.98 | 9.250 | 8.72 | 9.11 | 179212.0 |
| May 27, 2026 | 8.99 | 9.98 | 8.74 | 8.98 | 624445.0 |
| May 26, 2026 | 8.30 | 9.055 | 8.22 | 8.97 | 570692.0 |
| May 22, 2026 | 8.07 | 8.42 | 7.995 | 8.16 | 294996.0 |
| May 21, 2026 | 7.82 | 8.245 | 7.72 | 8.06 | 517776.0 |
| May 20, 2026 | 7.38 | 8.165 | 7.38 | 7.98 | 658503.0 |
| May 19, 2026 | 7.14 | 7.50 | 6.85 | 7.47 | 411284.0 |
| May 18, 2026 | 7.66 | 8.04 | 7.075 | 7.14 | 572015.0 |
| May 15, 2026 | 8.80 | 9.085 | 7.50 | 7.67 | 998050.0 |
| May 14, 2026 | 9.525 | 10.23 | 8.70 | 8.90 | 1.009M |
| May 13, 2026 | 8.99 | 9.025 | 8.570 | 8.85 | 953906.0 |
| May 12, 2026 | 8.84 | 9.25 | 8.730 | 8.915 | 275586.0 |
| May 11, 2026 | 8.64 | 9.265 | 8.45 | 8.81 | 466730.0 |
| May 08, 2026 | 8.87 | 9.00 | 8.54 | 8.64 | 295537.0 |
| May 07, 2026 | 8.96 | 9.00 | 8.68 | 8.85 | 168967.0 |
| May 06, 2026 | 9.61 | 9.61 | 9.02 | 9.02 | 180401.0 |
| May 05, 2026 | 9.31 | 9.52 | 9.215 | 9.41 | 201785.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 121.48 |
| Catalyst Pharmaceuticals, Inc. | 31.35 |
| Incyte Corp. | 105.41 |
| Inovio Pharmaceuticals, Inc. | 1.095 |
| Cellectar Biosciences, Inc. | 2.27 |
Price Related Metrics
| PS Ratio | 0.8979 |
| PEG Ratio | -0.0050 |
| Earnings Yield | -166.5% |
| Market Cap | 204.25M |
| PEGY Ratio | -0.0050 |